Histological Analysis of Bellafill Injected Tissue at Various Time Points

NCT03327311 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2017-10-31

No results posted yet for this study

Summary

This is a prospective, in vivo proof-of-concept clinical study, where histopathologic examinations will be conducted at various timepoints following Bellafill injections.

Conditions

  • Histopathology

Interventions

DEVICE

Bellafill

Bellafill injected into site of pre-planned surgery (i.e., mini-abdominoplasty or redundant abdominal tissue removal) at two depths (dermis \& deep dermis).

Sponsors & Collaborators

  • Suneva Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Nancy Seretta · Suneva Medical

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03327311 on ClinicalTrials.gov